COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
The Food and Drug Administration authorized for emergency use the first serology test to help identify individuals with antibodies to SARS-CoV-2 at the point of care.
The Food and Drug Administration reissued its emergency use authorization for the Abbott ID NOW COVID-19 test to indicate that the product is intended for specimens collected “from individuals who are suspected of COVID-19 by their health care provider within the first seven days of the onset of…
The Food and Drug Administration approved a new drug application for propofol injectable emulsion, an intravenous general anesthetic and sedation drug in short supply.
The Centers for Disease Control and Prevention updated its testing guidance for SARS-CoV-2, the virus that causes COVID-19.
The Food and Drug Administration approved dexmedetomidine hydrochloride in 0.9% sodium chloride injection for the sedation of initially intubated and mechanically ventilated patients in an intensive-care setting and of non-intubated patients prior to and/or during surgical and other procedures.
The Department of Health and Human Services today released its strategy for the public distribution of a COVID-19 vaccine.
The Food and Drug Administration released comparative performance data for 55 COVID-19 molecular diagnostic tests.
A Centers for Disease Control and Prevention study revealed that adults with positive SARS-CoV-2 test results were approximately twice as likely to have reported dining at restaurants within 14 days of developing symptoms compared with those whose test results were negative.
A new Centers for Disease Control and Prevention study is revealing the extent to which adults are bypassing medical care because of their COVID-19-related concerns.
The Centers for Disease Control and Prevention Sept. 17 at 2 p.m. ET will host a Clinician Outreach and Communication Activity webinar on using antivirals to treat influenza and whether the U.S. could see fewer cases, as indicated by data from the Southern Hemisphere’s 2020 flu season.